Stenocare A/S (CPH:STENO)
Denmark · Delayed Price · Currency is DKK 1.000
+0.010 (1.01%)
Jul 8, 2026, 4:43 PM CET
Stenocare Market Cap
Stenocare has a market cap or net worth of 42.76 million as of July 8, 2026. Its market cap has increased by 112.04% in one year.
Market Cap
42.76M
Enterprise Value
43.63M
Revenue
9.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.00
Market Cap Chart
Since May 18, 2020, Stenocare's market cap has decreased from 326.86M to 42.76M, a decrease of -86.92%. That is a compound annual growth rate of -28.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 42.76M | -33.11% |
| Dec 30, 2025 | 63.93M | 146.13% |
| Dec 30, 2024 | 25.97M | -43.63% |
| Dec 29, 2023 | 46.08M | -56.10% |
| Dec 30, 2022 | 104.96M | -11.04% |
| Dec 30, 2021 | 117.98M | -47.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| May 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.45T |
| Genmab | 112.20B |
| Coloplast | 89.53B |
| Demant | 58.17B |
| Gubra | 5.24B |
| BioPorto | 549.57M |
| Pharma Equity Group | 100.17M |
| ViroGates | 94.68M |